KV

Kamlesh Vasudev Bhai Patel

Active Director Director DIN 03404497
DIN 03404497 First appointment Apr 2011 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2011
Shareholding value •••• Premium profile

About Kamlesh Vasudev Bhai Patel

Data last updated:

Kamlesh Vasudev Bhai Patel is a Director at Wynburg Pharmaceuticals Private Limited (since 2011). The company operates in Pharma. Wynburg Pharmaceuticals Private Limited reported revenue of ₹1.10 Cr (FY 2025).

DIN 03404497
Primary Designation Director
Industry Pharma
First Appointment 26 Apr 2011
Oldest Company Age 15 yrs
Largest company Wynburg Pharmaceuticals Private Limited · ₹1.10 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Apr 20112011₹1.10 Cr (FY 2025)Active

Board colleagues of Kamlesh Vasudev Bhai Patel

Directorship timeline

Open interactive timeline →
Wynburg Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kamlesh Vasudev Bhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kamlesh Vasudev Bhai Patel

Kamlesh Vasudev Bhai Patel currently holds 1 directorship: Wynburg Pharmaceuticals Private Limited (Director, since 26 Apr 2011, revenue ₹1.10 Cr (FY 2025)).

Kamlesh Vasudev Bhai Patel was first appointed on 26 Apr 2011 as Director at Wynburg Pharmaceuticals Private Limited.

The current boards of Kamlesh Vasudev Bhai Patel's companies include Nitaben Kamlesh Bhai Patel (Wynburg Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available